余辉
光动力疗法
免疫系统
化学
癌症
生物物理学
程序性细胞死亡
免疫原性细胞死亡
光化学
癌症研究
材料科学
纳米技术
免疫疗法
医学
免疫学
生物
细胞凋亡
生物化学
内科学
物理
伽马射线暴
有机化学
天文
作者
Shiyi Liao,Youjuan Wang,Zhe Li,Ying Zhang,Xia Yin,Shuangyan Huan,Xiaobing Zhang,Sulai Liu,Guosheng Song
出处
期刊:Theranostics
[Ivyspring International Publisher]
日期:2022-01-01
卷期号:12 (16): 6883-6897
被引量:32
摘要
Rationale: Immunogenic cell death (ICD)-associated immunogenicity evoked through reactive oxygen species (ROS) is an efficient way to fight against the immune-dysfunctional microenvironment, so as to provoke potent anti-tumor immunity.However, the unknown ROS dose during cancer therapies may induce adverse immune responses (e.g., insufficient ICD, toxicity toward normal tissues or immune system).Methods: Herein, we developed a pyrido pyrazine -thiophene based semiconducting polymer as novel near-infrared (NIR) organic afterglow nanoparticles for the real-time visualization of self-generated ROS, during photodynamic-mediated immunogenic cell death.Specifically, we introduced the strong "acceptor" (pyrido pyrazine) into thiophene based semiconducting polymer to redshift emission wavelength, and further modulate the "donor" to afford more afterglow reaction sites and reducing ΔEst, so as to enhance luminescence intensity.Results: The semiconducting polymer-based afterglow nanoparticles exhibit strong afterglow emission with longer-wavelength emission (> 800 nm), compared with the reported organic afterglow nanoparticles (e.g., MEHPPV, PFODBT or Chlorin, < 690 nm), which endows this afterglow nanoparticles with a greatly improvement of signal to noise ratio.Moreover, the photodynamic effect of this afterglow nanoparticles can induce immunogenic cell death of cancer cells and further cause immune responses in mice. Conclusions:The NIR afterglow signal presents a good relationship with ROS generation, immunogenic cell death and outcome of treatment.Therefore, it was able to provide a non-invasive tool for predicting the degree of ICD that occurs during ROS-mediated cancer therapy and may contribute to precise immunotherapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI